Cargando…

Nanoparticle Delivery of Novel PDE4B Inhibitor for the Treatment of Alcoholic Liver Disease

The incidence of alcoholic liver disease (ALD) is increasing worldwide while no effective treatment has been approved. The progression of ALD has proven to be related to the upregulation of phosphodiesterase 4 (PDE4) expression, and PDE4 inhibitors showed potential to improve ALD. However, the appli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Jingyi, Kumar, Virender, Mahato, Ram I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501368/ https://www.ncbi.nlm.nih.gov/pubmed/36145643 http://dx.doi.org/10.3390/pharmaceutics14091894

Ejemplares similares

The use of micelles to deliver potential hedgehog pathway inhibitor for the treatment of liver fibrosis
por: Kumar, Virender, et al.
Publicado: (2019)

Next Generation PDE4 Inhibitors that Selectively Target PDE4B/D Subtypes: A Narrative Review
por: Blauvelt, Andrew, et al.
Publicado: (2023)

Comparison of the Pharmacological Profiles of Selective PDE4B and PDE4D Inhibitors in the Central Nervous System
por: Zhang, Chong, et al.
Publicado: (2017)

Design, Synthesis and Biological Evaluation of novel Hedgehog Inhibitors for treating Pancreatic Cancer
por: Kumar, Vinod, et al.
Publicado: (2017)

Treating COPD with PDE 4 inhibitors
por: Brown, William M
Publicado: (2007)

Novel PDE4 Inhibitors Derived from Chinese Medicine Forsythia
por: Coon, Tiffany A., et al.
Publicado: (2014)

Role of Phosphodiesterase 7 (PDE7) in T Cell Activity. Effects of Selective PDE7 Inhibitors and Dual PDE4/7 Inhibitors on T Cell Functions
por: Szczypka, Marianna
Publicado: (2020)

PDE4D and PDE4B Function in Distinct Subcellular Compartments in Mouse Embryonic Fibroblasts
por: Blackman, Brigitte E., et al.
Publicado: (2011)

Genotoxic potential of a novel PDE-4B inhibitor Apremilast by chromosomal aberration and micronucleus assay in mice
por: Afzal, Muhammad, et al.
Publicado: (2020)

Phosphodiesterase (PDE)-4 Inhibitors and COPD Correlation with Cancer
por: Organtzis, John, et al.
Publicado: (2014)

Pharmacophore Based Virtual Screening Approach to Identify Selective PDE4B Inhibitors
por: Gaurav, Anand, et al.
Publicado: (2017)

Pharmacophore Modeling and Virtual Screening for the Discovery of New type 4 cAMP Phosphodiesterase (PDE4) Inhibitors
por: Niu, Miaomiao, et al.
Publicado: (2013)

The anti-depressant effects of a novel PDE4 inhibitor derived from resveratrol
por: Yu, Yingcong, et al.
Publicado: (2021)

Myomegalin regulates Hedgehog pathway by controlling PDE4D at the centrosome
por: Peng, Hualing, et al.
Publicado: (2021)

Computational Study on Selective PDE9 Inhibitors on PDE9-Mg/Mg, PDE9-Zn/Mg, and PDE9-Zn/Zn Systems
por: Sivakumar, Dakshinamurthy, et al.
Publicado: (2021)

A Novel Catecholopyrimidine Based Small Molecule PDE4B Inhibitor Suppresses Inflammatory Cytokines in Atopic Mice
por: Purushothaman, Baskaran, et al.
Publicado: (2018)

Identification of pyrazolopyridazinones as PDEδ inhibitors
por: Papke, Björn, et al.
Publicado: (2016)

A Yeast-Based Chemical Screen Identifies a PDE Inhibitor That Elevates Steroidogenesis in Mouse Leydig Cells via PDE8 and PDE4 Inhibition
por: Demirbas, Didem, et al.
Publicado: (2013)

Inhaled Phosphodiesterase 4 (PDE4) Inhibitors for Inflammatory Respiratory Diseases
por: Phillips, Jonathan E.
Publicado: (2020)

Gemcitabine elaidate and ONC201 combination therapy inhibits pancreatic cancer in a KRAS mutated syngeneic mouse model
por: Mahato, Ram, et al.
Publicado: (2023)

Reduction of exacerbations by the PDE4 inhibitor roflumilast - the importance of defining different subsets of patients with COPD
por: Rennard, Stephen I, et al.
Publicado: (2011)

An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022
por: Crocetti, Letizia, et al.
Publicado: (2022)

PDE4 Inhibitors: Profiling Hits through the Multitude of Structural Classes
por: Jin, Jian, et al.
Publicado: (2023)

Docking based screening and molecular dynamics simulations to identify potential selective PDE4B inhibitor
por: Al-Nema, Mayasah, et al.
Publicado: (2020)

PDE4B gene polymorphism in Russian patients with panic disorder
por: Malakhova, Alena V, et al.
Publicado: (2019)

Efficacy and safety of CHF6001, a novel inhaled PDE4 inhibitor in COPD: the PIONEER study
por: Singh, Dave, et al.
Publicado: (2020)

Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease
por: Facchinetti, Fabrizio, et al.
Publicado: (2021)

Central serous chorioretinopathy treatment with a systemic PDE5 and PDE6 inhibitor (sildenafil)
por: Coleman, D. Jackson, et al.
Publicado: (2020)

Activation of PDE10 and PDE11
por: Jäger, Ronald, et al.
Publicado: (2011)

Differential Expression and Function of PDE8 and PDE4 in Effector T cells: Implications for PDE8 as a Drug Target in Inflammation
por: Vang, Amanda G., et al.
Publicado: (2016)

Novel variants in PDE6A and PDE6B genes and its phenotypes in patients with retinitis pigmentosa in Chinese families
por: Li, Yuyu, et al.
Publicado: (2022)

The efficacy of PDE5 inhibitors in diabetic patients
por: Swiecicka, Agnieszka
Publicado: (2022)

PDE5 inhibitor drugs for use in dementia
por: Hainsworth, Atticus H., et al.
Publicado: (2023)

Evaluation of the acute oral toxicity and antipsychotic activity of a dual inhibitor of PDE1B and PDE10A in rat model of schizophrenia
por: Al-Nema, Mayasah, et al.
Publicado: (2022)

PDE4 inhibitors as potential therapeutic agents in the treatment of COPD-focus on roflumilast
por: Boswell-Smith, Victoria, et al.
Publicado: (2007)

Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD
por: Singh, Dave, et al.
Publicado: (2019)

Assessment of PDE4 Inhibitor-Induced Hypothermia as a Correlate of Nausea in Mice
por: Boyd, Abigail, et al.
Publicado: (2021)

The PDE4 Inhibitor Tanimilast Restrains the Tissue-Damaging Properties of Human Neutrophils
por: Schioppa, Tiziana, et al.
Publicado: (2022)

Modulation of oxazolone-induced hypersensitivity in mice by selective PDE inhibitors
por: Moodley, I., et al.
Publicado: (1995)

First Optimization of Novel, Potent, Selective PDE11A4 Inhibitors for Age-Related Cognitive Decline
por: Mahmood, Shams ul, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_im6get4emlldog5qr8hmopj1an